2019
DOI: 10.3390/cells8080897
|View full text |Cite
|
Sign up to set email alerts
|

Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats

Abstract: Background: Nod-like receptor protein 3 (NLRP3) inflammasome is a crucial contributor in the inflammatory process during cerebral ischemia/reperfusion (I/R) injury. ATF4 plays a pivotal role in the pathogenesis of cerebral I/R injury, however, its function and underlying mechanism are not fully characterized yet. In the current study, we examined whether ATF4 ameliorates cerebral I/R injury by inhibiting NLRP3 inflammasome activation and whether mitophagy is involved in this process. In addition, we explored t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
62
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 83 publications
(65 citation statements)
references
References 49 publications
(69 reference statements)
3
62
0
Order By: Relevance
“…Inhibition of the AMPK/Sirt3 signaling pathway abolished Mfn2-mediated protection on I/R-treated N2a cells through induction of mitochondrial damage. This finding defines a Mfn2/AMPK/Sirt3 axis as a new regulator of mitochondrial homeostasis and cell survival in the context of cardio-cerebrovascular I/R injury (Chen et al, 2019;He et al, 2019). Several protective approaches have been developed to regulate mitochondrial function and attenuate brain/heart damage after I/R injury.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Inhibition of the AMPK/Sirt3 signaling pathway abolished Mfn2-mediated protection on I/R-treated N2a cells through induction of mitochondrial damage. This finding defines a Mfn2/AMPK/Sirt3 axis as a new regulator of mitochondrial homeostasis and cell survival in the context of cardio-cerebrovascular I/R injury (Chen et al, 2019;He et al, 2019). Several protective approaches have been developed to regulate mitochondrial function and attenuate brain/heart damage after I/R injury.…”
Section: Discussionmentioning
confidence: 93%
“…Improvement of mitochondrial biogenesis and promotion of glucose metabolism through activation of Rac2 has been found to sustain brain function after I/R injury (Xia et al, 2020). Parkin-dependent mitophagy is significantly depressed in reperfused brain, and activation of mitophagy sends pro-survival signals to neurons in the context of I/R injury (He et al, 2019). Although extracellular signal-regulated kinase (ERK) has been found to be a regulator of cancer proliferation, inhibition of the ERK signaling pathway through administration of PD98059 significantly protects the brain against mitochondria-mediated apoptosis in I/R injury .…”
Section: Discussionmentioning
confidence: 99%
“…Recent study has reported that electroacupuncture improves CI/R injury by activating Pink1/Parkin-induced mitophagy [7]. Pink1/Parkin-mediated mitophagy ameliorates CI/R injury by eliminating ATF4 and NLRP3 inflammasome [8]. However, Bcl-2/E1B 19 kDa-interacting protein 3 (BNIP3) is highly expressed after CI/R, which causes excessive activation of mitophagy, triggers delayed cell death, and aggravates CI/R injury [9].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, mitophagy is thought to mediate the protective effect of ischemic preconditioning in kidneys by targeting a series of biological events, including damaged mitochondrial clearance, mitophagosome formation, and mitochondrial depolarization [41]. In addition, crucial roles for mitophagy in affording neuroprotection against IR cerebral injury and alleviating metabolic dysfunction have also been reported [20,[42][43][44]. Under tumor-related hypoxic conditions, the activation of mitophagy is involved in assisting tumor cell survival and promoting cancer, while BNIP3-or BNIP3L-mediated mitophagy may act as a suppressor of tumorigenesis and metastasis in breast cancer or xenograft conditions [45][46][47].…”
Section: Discussionmentioning
confidence: 99%